Full Text
EPH161 Estimation of the Size of the Eligible Population in the United States for Resmetirom: A Novel Investigational Therapy for NASH

Abstract

Authors

Y Kim J Fishman Z Smith E Bercaw T OConnell

Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×